126 related articles for article (PubMed ID: 10807417)
1. Review article: the stages of gastrointestinal carcinogenesis--application of rodent models to human disease.
Pitot HC; Hikita H; Dragan Y; Sargent L; Haas M
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():153-60. PubMed ID: 10807417
[TBL] [Abstract][Full Text] [Related]
2. Short-term fasting and the reversal of the stage of promotion in rat hepatocarcinogenesis: role of cell replication, apoptosis, and gene expression.
Hikita H; Vaughan J; Babcock K; Pitot HC
Toxicol Sci; 1999 Dec; 52(2 Suppl):17-23. PubMed ID: 10630586
[TBL] [Abstract][Full Text] [Related]
3. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
Pascale RM; Simile MM; Feo F
Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies.
Feo F; Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi D
Crit Rev Oncog; 2000; 11(1):19-62. PubMed ID: 10795626
[TBL] [Abstract][Full Text] [Related]
5. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
[TBL] [Abstract][Full Text] [Related]
6. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
Santoni-Rugiu E; Preisegger KH; Kiss A; Audolfsson T; Shiota G; Schmidt EV; Thorgeirsson SS
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9577-82. PubMed ID: 8790372
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.
Simile MM; Pagnan G; Pastorino F; Brignole C; De Miglio MR; Muroni MR; Asara G; Frau M; Seddaiu MA; Calvisi DF; Feo F; Ponzoni M; Pascale RM
Carcinogenesis; 2005 Feb; 26(2):417-27. PubMed ID: 15498786
[TBL] [Abstract][Full Text] [Related]
9. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
Pitot HC; Dragan Y; Sargent L; Xu YH
Environ Health Perspect; 1991 Jun; 93():181-9. PubMed ID: 1723043
[TBL] [Abstract][Full Text] [Related]
11. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
[TBL] [Abstract][Full Text] [Related]
12. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation in gastrointestinal carcinogenesis.
Sunter JP
Scand J Gastroenterol Suppl; 1984; 104():45-55. PubMed ID: 6597549
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS; Santoni-Rugiu E
Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
[TBL] [Abstract][Full Text] [Related]
15. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes and suppressor genes: their involvement in colon cancer.
Rigas B
J Clin Gastroenterol; 1990 Oct; 12(5):494-9. PubMed ID: 2229991
[TBL] [Abstract][Full Text] [Related]
17. The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis.
Mehta R
Cancer Lett; 1995 Jun; 93(1):85-102. PubMed ID: 7600546
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
Sipos F; Firneisz G; Műzes G
World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models.
Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M
Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812
[TBL] [Abstract][Full Text] [Related]
20. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
Xin B; Yamamoto M; Fujii K; Ooshio T; Chen X; Okada Y; Watanabe K; Miyokawa N; Furukawa H; Nishikawa Y
Oncogene; 2017 Sep; 36(36):5087-5097. PubMed ID: 28481866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
